Medicine & Life Sciences

1. T-Lymphocytes 100%
2. Ovarian Neoplasms 88%
3. Neoplasms 84%
4. Immunity 83%
5. Breast Neoplasms 78%
6. Vaccines 54%
7. Subunit Vaccines 49%
8. Neoplasm Antigens 44%
9. Regulatory T-Lymphocytes 42%
10. Folate Receptor 1 40%
11. Epitopes 38%
12. Dendritic Cells 36%
13. Ovarian Epithelial Carcinoma 35%
14. Trastuzumab 34%
15. Vaccination 32%
16. Immunotherapy 30%
17. Antigens 29%
18. Peptides 29%
19. Cytokines 26%
20. Antibodies 24%
21. Cancer Vaccines 24%
22. HLA-A2 Antigen 22%
23. Immunization 22%
24. Immune System 22%
25. Therapeutics 21%
26. Survival 21%
27. Epithelial-Mesenchymal Transition 21%
28. Protein Kinase C 21%
29. Breast 21%
30. Rheumatoid Arthritis 20%
31. Breast Diseases 18%
32. Biomarkers 17%
33. Protein Kinase C beta 16%
34. Tumor Microenvironment 16%
35. Proteins 16%
36. Neoplastic Stem Cells 15%
37. Granulocyte-Macrophage Colony-Stimulating Factor 15%
38. HLA Antigens 14%
39. Recurrence 14%
40. Transgenic Mice 14%
41. Helper-Inducer T-Lymphocytes 14%
42. Single Nucleotide Polymorphism 13%
43. Triple Negative Breast Neoplasms 12%
44. Genes 12%
45. Lipopolysaccharides 12%
46. Interleukin-2 11%
47. Interleukin-12 11%
48. Cell- and Tissue-Based Therapy 11%
49. HLA-DR Antigens 10%
50. Cellular Immunity 10%